CD4 and Alzheimer disease: To evaluate the immunosuppressive potential of AD-MSCs, we performed a co-culture assay with PBMCs and analysed PHA-activated CD4 + and CD8 + T cell proliferation using cell trace CFSE staining and flow cytometry (Fig. 4B).